Jan 23, 2026 08:01AM
Jan 23, 2026 08:00AM
Nov 26, 2025 08:00AM
Nov 26, 2025 08:00AM
Nov 24, 2025 10:00AM
Nov 24, 2025 10:00AM
Sep 19, 2025 09:00AM Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Sep 11, 2025 08:01AM
Sep 11, 2025 08:00AM
Mar 3, 2025 08:23AM
Mar 3, 2025 08:22AM
Jul 19, 2024 09:00AM
Jun 11, 2024 06:42AM
May 28, 2024 08:12AM Enlivex Therapeutics (ENLV) Announces up to $15 Million Registered Direct Offering
May 28, 2024 08:12AM
Feb 21, 2024 08:30AM
Nov 21, 2023 07:00AM
Feb 15, 2023 08:00AM
Dec 5, 2022 08:00AM
Nov 28, 2022 08:03AM
Nov 28, 2022 08:00AM Enlivex Receives Allocetra IND Clearance From The U.S. Food And Drug Administration For Treatment Of Patients with Advanced Solid Malignancies
Sep 6, 2022 08:08AM
Sep 6, 2022 08:00AM
Aug 24, 2022 08:00AM
Aug 22, 2022 08:00AM
Jul 6, 2022 08:36AM
Jun 6, 2022 08:00AM
May 9, 2022 09:05AM Enlivex Presented Substantial Survival Benefit of Allocetra in Combination with Immune Checkpoint Inhibitor in Mesothelioma Cancer Study at the International Society for Cell and Gene Therapy Annual 2
Apr 29, 2022 08:41AM
Feb 22, 2022 08:00AM
Nov 22, 2021 08:00AM
Aug 9, 2021 08:00AM
Aug 2, 2021 08:00AM
Dec 21, 2020 08:09AM
Dec 21, 2020 08:00AM Enlivex Announces Pre-Print Publication of Full Results from Phase Ib Severe Sepsis Trial on medRxiv
Nov 17, 2020 08:18AM
Oct 1, 2020 09:30AM
Aug 25, 2020 09:30AM
Mar 18, 2020 08:04AM
Mar 18, 2020 08:00AM
Mar 18, 2020 08:00AM
Mar 2, 2020 09:24AM Pre-Open Stock Movers 03/02: (FTSV) (TRIL) (TWTR) Higher; (BIOC) (ENLV) (NVAX) Lower (more...)
Nov 18, 2019 08:36AM
Nov 18, 2019 08:30AM
Nov 18, 2019 08:30AM
Nov 4, 2019 07:32AM
Nov 4, 2019 07:30AM
Nov 4, 2019 07:30AM
Aug 19, 2019 07:33AM Enlivex Therapeutics Ltd. (ENLV) Reports Positive Outcome from Safety Committee Review of Ongoing Ph. Ib Clinical Trial; Enrollment Of Last Study Cohort Approved
Aug 19, 2019 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All